Polypharmacy and cognitive outcomes in elderly inpatients with Alzheimer's disease: A three-year retrospective study.

Key Points

• To investigate the relationship between polypharmacy and cognitive outcomes in elderly inpatients with Alzheimer's disease.
• Conducted a three-year retrospective study
• Focused on elderly inpatients diagnosed with Alzheimer's disease
• Analyzed medication management practices regarding cognitive outcomes.
• Identified polypharmacy as a significant risk factor for cognitive decline
• Suggested that structured medication management can mitigate cognitive decline
• Showed a correlation between polypharmacy levels and worsening cognitive function.